Risk of COVID-19 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional DMARDs in Italy

OBJECTIVES: To ascertain if hydroxychloroquine (HCQ)/chloroquine (CLQ) and other conventional disease-modifying anti-rheumatic drugs (cDMARDs) use, and rheumatic diseases per se, may be associated with COVID-19-related risk of hospitalization and mortality. METHODS: This case-control study nested wi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Rheumatology (Oxford)
Main Authors: Alegiani, Stefania Spila, Crisafulli, Salvatore, Rossi, Paolo Giorgi, Mancuso, Pamela, Salvarani, Carlo, Atzeni, Fabiola, Gini, Rosa, Kirchmayer, Ursula, Belleudi, Valeria, Kurotschka, Peter Konstantin, Leoni, Olivia, Ludergnani, Monica, Ferroni, Eliana, Baracco, Susanna, Massari, Marco, Trifirò, Gianluca
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2021
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8083276/
https://ncbi.nlm.nih.gov/pubmed/33856453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keab348
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares